GlassScriptPhysician profile
Ian S Mcdougall
NPI 1356605927
$7,674.37
in general payments reported to CMS, 2019-2025
17 companies · $290 in 2025
The $290 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,399 · 2020: $131 · 2021: $981 · 2022: $858 · 2023: $2,845 · 2024: $170 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,057 · Travel and Lodging: $1,247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,057.19 |
| Travel and Lodging | $1,247.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,882.61 | 2021-2024 | Synchromedii, Intellis Adaptivestim, Mazor X System |
| Medtronic USA, INC. | $2,236.91 | 2019 | |
| Globus Medical, INC. | $317.96 | 2021 | |
| Davol INC. | $311.52 | 2022 | |
| Intrinsic Therapeutics | $266.54 | 2023 | Barricaid Acd (Annular Closure Device) |
| Abbott Laboratories | $259.57 | 2021-2025 | Eterna |
| Allergan, INC. | $187.41 | 2021 | |
| Stryker Corporation | $159.71 | 2023 | Na |
| Acera Surgical, INC. | $156.99 | 2023 | Restrata Wound Matrix |
| Abbvie INC. | $143.40 | 2024 | |
| Boston Scientific Corporation | $142.78 | 2025 | Wavewriter Alpha Prime 16 |
| Kerecis Limited | $141.08 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Nuvasive, INC. | $136.81 | 2019 | |
| Si-Bone, INC. | $131.45 | 2020 | |
| Smith+Nephew, INC. | $124.98 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ulrich Medical USA, INC. | $48.95 | 2022 | |
| Kyocera Medical Technologies, INC. | $25.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Mcdougall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.